Worth reading
72In focus
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
450000
unitsWording
Definitive
How definitive the wording is.Details of issuance or disposal
Completion of the exercise of the 38th Series Stock Acquisition Rights issued through a third-party allotment
Intended allottee
EVO FUND
Terms of the stock acquisition rights
Number of Stock Acquisition Rights
Total issued: 450,000 rights; exercised: 450,000 rights; remaining: 0 rights
Most recent equity financing
Issuance of new shares and the 38th Series Stock Acquisition Rights through a third-party allotment announced on 17 November 2025 (the detailed amount is not stated in this document)
| Item | Details |
|---|---|
| Type of issuance or disposal | Completion of the exercise of the 38th Series Stock Acquisition Rights issued through a third-party allotment |
| Intended allottee | EVO FUND |
| Number of Stock Acquisition Rights | Total issued: 450,000 rights; exercised: 450,000 rights; remaining: 0 rights |
| Most recent equity financing | Issuance of new shares and the 38th Series Stock Acquisition Rights through a third-party allotment announced on 17 November 2025 (the detailed amount is not stated in this document) |
Items this document does not state (24)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.All of the 38th Series Stock Acquisition Rights, approved by resolutions of the Board of Directors held on 14 November 2025 and an extraordinary general meeting of shareholders held on 19 December 2025, were fully exercised as of 7 July 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.